Correction biochemical parameters of ejaculate in applying suppositories Vitaprost Fortе in men with chronic inflammatory diseases prostateviscular complex complicated excretory-toxic sterility
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Materials and methods. 88 patients were examined for infertility. The age of the patients ranged from 24 to 37 years (mean age 29.3±1.3 years). Patients were divided into three groups. The first clinical group included 52 patients who received, along with traditional therapy, Vitaprost Forte in the second stage of treatment. Patients of control group 2 (36 patients) received similar treatment with the exception of Vitaprost Forte. In the third, the control group included healthy men.
The drug Vitaprost Fort was prescribed one rectal suppository after enema or bowel movement once a day in the evening, the course – 90 days. At the beginning and after treatment, the biochemical parameters of the spermogram were evaluated.
Results. In the group of patients who received Vitaprost Fort in a complex treatment, all the indicators significantly increased, and such indicators as LC and FH reached the norm. It was found that the difference between the clinical and control groups is significant (p<0.05). This indicates a high therapeutic value of the drug Vitaprost Forte.
The conclusion. Vitaprost Forte is a highly effective drug for the treatment of chronic inflammatory diseases of male genital organs, complicated by excretory-toxic infertility (ETB).
The results obtained make it possible to recommend Vitaprost Forte for complex treatment of chronic inflammatory diseases of male genital organs, complicated by ETI.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Сексологія і андрологія / Під ред акад. О.Ф. Возіанова та проф. І.І. Горпинченка. – К.: Вид. «Здоров’я», 1996.
Проскура О.В. Неспецифические простатиты и везикулиты: Руководство по клинической урологии/ Под ред. А.Я. Пытеля. – М., 1970. – С. 193–208.
Кан Д.В., Сегал А.С., Кузьменко А.Н. Диагностика и лечение хронического неспецифического простатита: Метод. рекомендации – М., 1980.
Тиктинский О.Л. Воспалительные неспецифические заболевания мочеполовых органов. – Ленинград. – 1984.
Lubasch A., Keller I., Borner K., Koeppe P., Lode H. Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin and moxifloxacin after single oral administration in healthy volunteers. Antimicrob Agents Chemother 2000:44:2600–3.
Ильин И.И. Негонококковые уретриты у мужчин., 2-е изд. перераб. и доп. – М.: Медицина, 1993. – 256 с.
Мавров И.И., Бухарович В.Г., Глухенький Б.Т. и др. Контактные инфекции, передающиеся половым путем/Пoд ред. И.И. Маврова. – К.: Здоровья, 1989. – 230 с.
Скрипкин Ю.К., Шарапова Г.Я., Селисский Г.Д. Болезни, передающиеся при половых контактах. – Медицина, 1985. – 284 с.
Vanuffel P., Cocito C. Mechanism of action of streptogramins and macrolides. Drugs 1996;51(Suppl.1):20–30.
